 | • レポートコード：QYR2104Z3676 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、メドロキシプロゲステロンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、カプセル、長時間作用型注射（粉末）、シクロプロゲステロンオイル注射、メドロキシプロゲステロンシリコーンゴム膣リング）、用途別市場規模（腎臓がん、乳がん、子宮内膜がん、前立腺がん、長時間作用型避妊）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・メドロキシプロゲステロンの市場動向 ・企業の競争状況、市場シェア ・メドロキシプロゲステロンの種類別市場規模（注射、錠剤、カプセル、長時間作用型注射（粉末）、シクロプロゲステロンオイル注射、メドロキシプロゲステロンシリコーンゴム膣リング） ・メドロキシプロゲステロンの用途別市場規模（腎臓がん、乳がん、子宮内膜がん、前立腺がん、長時間作用型避妊） ・メドロキシプロゲステロンの北米市場規模2016-2027（アメリカ、カナダ） ・メドロキシプロゲステロンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・メドロキシプロゲステロンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メドロキシプロゲステロンの中南米市場規模2016-2027（メキシコ、ブラジル） ・メドロキシプロゲステロンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Carlo Erba、Pfizer、Polichem、Nanjing Chengong Pharmaceutical、Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)、Beijing Yimin Pharmaceutical、Guangzhou Kanghe Pharmaceutical、Zhejiang Xianju Pharmaceutical、Beijing Kangbide Pharmaceutical、Harbin Outi Pharmaceutical、Hong Kong Aomei Pharmaceutical Factory、Jiangxi Zezhong Pharmaceutical、Nanjing Housheng Pharmaceutical、Yantai Luyin Pharmaceutical、Beijing Langyi Pharmaceutical、Sinopharm group、Chuankang Pharmaceutical、GMP、Hubei Gedian Renfu Pharmaceutical、Shanghai Xinhualian Pharmaceutical、China Resources Zizhu Pharmaceutical、Guangzhou Langsheng Pharmaceutical） ・結論 |
MedroxyProgesterone
Market Analysis and Insights: Global MedroxyProgesterone Market
The global MedroxyProgesterone market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global MedroxyProgesterone market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global MedroxyProgesterone market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global MedroxyProgesterone market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global MedroxyProgesterone market.
Global MedroxyProgesterone Scope and Market Size
MedroxyProgesterone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global MedroxyProgesterone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Tablets
Capsule
Long-Acting Injection (Powder)
Cycloprogesterone Oil Injection
Medroxyprogesterone Silicone Rubber Vaginal Ring
Segment by Application
Kidney Cancer
Breast Cancer
Endometrial Cancer
Prostate Cancer
Long-Acting Contraception
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Carlo Erba
Pfizer
Polichem
Nanjing Chengong Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Beijing Yimin Pharmaceutical
Guangzhou Kanghe Pharmaceutical
Zhejiang Xianju Pharmaceutical
Beijing Kangbide Pharmaceutical
Harbin Outi Pharmaceutical
Hong Kong Aomei Pharmaceutical Factory
Jiangxi Zezhong Pharmaceutical
Nanjing Housheng Pharmaceutical
Yantai Luyin Pharmaceutical
Beijing Langyi Pharmaceutical
Sinopharm group
Chuankang Pharmaceutical
GMP
Hubei Gedian Renfu Pharmaceutical
Shanghai Xinhualian Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MedroxyProgesterone Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Tablets
1.2.4 Capsule
1.2.5 Long-Acting Injection (Powder)
1.2.6 Cycloprogesterone Oil Injection
1.2.7 Medroxyprogesterone Silicone Rubber Vaginal Ring
1.3 Market by Application
1.3.1 Global MedroxyProgesterone Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Kidney Cancer
1.3.3 Breast Cancer
1.3.4 Endometrial Cancer
1.3.5 Prostate Cancer
1.3.6 Long-Acting Contraception
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global MedroxyProgesterone Market Perspective (2016-2027)
2.2 MedroxyProgesterone Growth Trends by Regions
2.2.1 MedroxyProgesterone Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 MedroxyProgesterone Historic Market Share by Regions (2016-2021)
2.2.3 MedroxyProgesterone Forecasted Market Size by Regions (2022-2027)
2.3 MedroxyProgesterone Industry Dynamic
2.3.1 MedroxyProgesterone Market Trends
2.3.2 MedroxyProgesterone Market Drivers
2.3.3 MedroxyProgesterone Market Challenges
2.3.4 MedroxyProgesterone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top MedroxyProgesterone Players by Revenue
3.1.1 Global Top MedroxyProgesterone Players by Revenue (2016-2021)
3.1.2 Global MedroxyProgesterone Revenue Market Share by Players (2016-2021)
3.2 Global MedroxyProgesterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by MedroxyProgesterone Revenue
3.4 Global MedroxyProgesterone Market Concentration Ratio
3.4.1 Global MedroxyProgesterone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MedroxyProgesterone Revenue in 2020
3.5 MedroxyProgesterone Key Players Head office and Area Served
3.6 Key Players MedroxyProgesterone Product Solution and Service
3.7 Date of Enter into MedroxyProgesterone Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MedroxyProgesterone Breakdown Data by Type
4.1 Global MedroxyProgesterone Historic Market Size by Type (2016-2021)
4.2 Global MedroxyProgesterone Forecasted Market Size by Type (2022-2027)
5 MedroxyProgesterone Breakdown Data by Application
5.1 Global MedroxyProgesterone Historic Market Size by Application (2016-2021)
5.2 Global MedroxyProgesterone Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America MedroxyProgesterone Market Size (2016-2027)
6.2 North America MedroxyProgesterone Market Size by Type
6.2.1 North America MedroxyProgesterone Market Size by Type (2016-2021)
6.2.2 North America MedroxyProgesterone Market Size by Type (2022-2027)
6.2.3 North America MedroxyProgesterone Market Size by Type (2016-2027)
6.3 North America MedroxyProgesterone Market Size by Application
6.3.1 North America MedroxyProgesterone Market Size by Application (2016-2021)
6.3.2 North America MedroxyProgesterone Market Size by Application (2022-2027)
6.3.3 North America MedroxyProgesterone Market Size by Application (2016-2027)
6.4 North America MedroxyProgesterone Market Size by Country
6.4.1 North America MedroxyProgesterone Market Size by Country (2016-2021)
6.4.2 North America MedroxyProgesterone Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe MedroxyProgesterone Market Size (2016-2027)
7.2 Europe MedroxyProgesterone Market Size by Type
7.2.1 Europe MedroxyProgesterone Market Size by Type (2016-2021)
7.2.2 Europe MedroxyProgesterone Market Size by Type (2022-2027)
7.2.3 Europe MedroxyProgesterone Market Size by Type (2016-2027)
7.3 Europe MedroxyProgesterone Market Size by Application
7.3.1 Europe MedroxyProgesterone Market Size by Application (2016-2021)
7.3.2 Europe MedroxyProgesterone Market Size by Application (2022-2027)
7.3.3 Europe MedroxyProgesterone Market Size by Application (2016-2027)
7.4 Europe MedroxyProgesterone Market Size by Country
7.4.1 Europe MedroxyProgesterone Market Size by Country (2016-2021)
7.4.2 Europe MedroxyProgesterone Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific MedroxyProgesterone Market Size (2016-2027)
8.2 Asia-Pacific MedroxyProgesterone Market Size by Type
8.2.1 Asia-Pacific MedroxyProgesterone Market Size by Type (2016-2021)
8.2.2 Asia-Pacific MedroxyProgesterone Market Size by Type (2022-2027)
8.2.3 Asia-Pacific MedroxyProgesterone Market Size by Type (2016-2027)
8.3 Asia-Pacific MedroxyProgesterone Market Size by Application
8.3.1 Asia-Pacific MedroxyProgesterone Market Size by Application (2016-2021)
8.3.2 Asia-Pacific MedroxyProgesterone Market Size by Application (2022-2027)
8.3.3 Asia-Pacific MedroxyProgesterone Market Size by Application (2016-2027)
8.4 Asia-Pacific MedroxyProgesterone Market Size by Region
8.4.1 Asia-Pacific MedroxyProgesterone Market Size by Region (2016-2021)
8.4.2 Asia-Pacific MedroxyProgesterone Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America MedroxyProgesterone Market Size (2016-2027)
9.2 Latin America MedroxyProgesterone Market Size by Type
9.2.1 Latin America MedroxyProgesterone Market Size by Type (2016-2021)
9.2.2 Latin America MedroxyProgesterone Market Size by Type (2022-2027)
9.2.3 Latin America MedroxyProgesterone Market Size by Type (2016-2027)
9.3 Latin America MedroxyProgesterone Market Size by Application
9.3.1 Latin America MedroxyProgesterone Market Size by Application (2016-2021)
9.3.2 Latin America MedroxyProgesterone Market Size by Application (2022-2027)
9.3.3 Latin America MedroxyProgesterone Market Size by Application (2016-2027)
9.4 Latin America MedroxyProgesterone Market Size by Country
9.4.1 Latin America MedroxyProgesterone Market Size by Country (2016-2021)
9.4.2 Latin America MedroxyProgesterone Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa MedroxyProgesterone Market Size (2016-2027)
10.2 Middle East & Africa MedroxyProgesterone Market Size by Type
10.2.1 Middle East & Africa MedroxyProgesterone Market Size by Type (2016-2021)
10.2.2 Middle East & Africa MedroxyProgesterone Market Size by Type (2022-2027)
10.2.3 Middle East & Africa MedroxyProgesterone Market Size by Type (2016-2027)
10.3 Middle East & Africa MedroxyProgesterone Market Size by Application
10.3.1 Middle East & Africa MedroxyProgesterone Market Size by Application (2016-2021)
10.3.2 Middle East & Africa MedroxyProgesterone Market Size by Application (2022-2027)
10.3.3 Middle East & Africa MedroxyProgesterone Market Size by Application (2016-2027)
10.4 Middle East & Africa MedroxyProgesterone Market Size by Country
10.4.1 Middle East & Africa MedroxyProgesterone Market Size by Country (2016-2021)
10.4.2 Middle East & Africa MedroxyProgesterone Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Carlo Erba
11.1.1 Carlo Erba Company Details
11.1.2 Carlo Erba Business Overview
11.1.3 Carlo Erba MedroxyProgesterone Introduction
11.1.4 Carlo Erba Revenue in MedroxyProgesterone Business (2016-2021)
11.1.5 Carlo Erba Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer MedroxyProgesterone Introduction
11.2.4 Pfizer Revenue in MedroxyProgesterone Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Polichem
11.3.1 Polichem Company Details
11.3.2 Polichem Business Overview
11.3.3 Polichem MedroxyProgesterone Introduction
11.3.4 Polichem Revenue in MedroxyProgesterone Business (2016-2021)
11.3.5 Polichem Recent Development
11.4 Nanjing Chengong Pharmaceutical
11.4.1 Nanjing Chengong Pharmaceutical Company Details
11.4.2 Nanjing Chengong Pharmaceutical Business Overview
11.4.3 Nanjing Chengong Pharmaceutical MedroxyProgesterone Introduction
11.4.4 Nanjing Chengong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.4.5 Nanjing Chengong Pharmaceutical Recent Development
11.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.5.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
11.5.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.5.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Introduction
11.5.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in MedroxyProgesterone Business (2016-2021)
11.5.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.6 Beijing Yimin Pharmaceutical
11.6.1 Beijing Yimin Pharmaceutical Company Details
11.6.2 Beijing Yimin Pharmaceutical Business Overview
11.6.3 Beijing Yimin Pharmaceutical MedroxyProgesterone Introduction
11.6.4 Beijing Yimin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.6.5 Beijing Yimin Pharmaceutical Recent Development
11.7 Guangzhou Kanghe Pharmaceutical
11.7.1 Guangzhou Kanghe Pharmaceutical Company Details
11.7.2 Guangzhou Kanghe Pharmaceutical Business Overview
11.7.3 Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Introduction
11.7.4 Guangzhou Kanghe Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.7.5 Guangzhou Kanghe Pharmaceutical Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Details
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical MedroxyProgesterone Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Beijing Kangbide Pharmaceutical
11.9.1 Beijing Kangbide Pharmaceutical Company Details
11.9.2 Beijing Kangbide Pharmaceutical Business Overview
11.9.3 Beijing Kangbide Pharmaceutical MedroxyProgesterone Introduction
11.9.4 Beijing Kangbide Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.9.5 Beijing Kangbide Pharmaceutical Recent Development
11.10 Harbin Outi Pharmaceutical
11.10.1 Harbin Outi Pharmaceutical Company Details
11.10.2 Harbin Outi Pharmaceutical Business Overview
11.10.3 Harbin Outi Pharmaceutical MedroxyProgesterone Introduction
11.10.4 Harbin Outi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.10.5 Harbin Outi Pharmaceutical Recent Development
11.11 Hong Kong Aomei Pharmaceutical Factory
11.11.1 Hong Kong Aomei Pharmaceutical Factory Company Details
11.11.2 Hong Kong Aomei Pharmaceutical Factory Business Overview
11.11.3 Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Introduction
11.11.4 Hong Kong Aomei Pharmaceutical Factory Revenue in MedroxyProgesterone Business (2016-2021)
11.11.5 Hong Kong Aomei Pharmaceutical Factory Recent Development
11.12 Jiangxi Zezhong Pharmaceutical
11.12.1 Jiangxi Zezhong Pharmaceutical Company Details
11.12.2 Jiangxi Zezhong Pharmaceutical Business Overview
11.12.3 Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Introduction
11.12.4 Jiangxi Zezhong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.12.5 Jiangxi Zezhong Pharmaceutical Recent Development
11.13 Nanjing Housheng Pharmaceutical
11.13.1 Nanjing Housheng Pharmaceutical Company Details
11.13.2 Nanjing Housheng Pharmaceutical Business Overview
11.13.3 Nanjing Housheng Pharmaceutical MedroxyProgesterone Introduction
11.13.4 Nanjing Housheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.13.5 Nanjing Housheng Pharmaceutical Recent Development
11.14 Yantai Luyin Pharmaceutical
11.14.1 Yantai Luyin Pharmaceutical Company Details
11.14.2 Yantai Luyin Pharmaceutical Business Overview
11.14.3 Yantai Luyin Pharmaceutical MedroxyProgesterone Introduction
11.14.4 Yantai Luyin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.14.5 Yantai Luyin Pharmaceutical Recent Development
11.15 Beijing Langyi Pharmaceutical
11.15.1 Beijing Langyi Pharmaceutical Company Details
11.15.2 Beijing Langyi Pharmaceutical Business Overview
11.15.3 Beijing Langyi Pharmaceutical MedroxyProgesterone Introduction
11.15.4 Beijing Langyi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.15.5 Beijing Langyi Pharmaceutical Recent Development
11.16 Sinopharm group
11.16.1 Sinopharm group Company Details
11.16.2 Sinopharm group Business Overview
11.16.3 Sinopharm group MedroxyProgesterone Introduction
11.16.4 Sinopharm group Revenue in MedroxyProgesterone Business (2016-2021)
11.16.5 Sinopharm group Recent Development
11.17 Chuankang Pharmaceutical
11.17.1 Chuankang Pharmaceutical Company Details
11.17.2 Chuankang Pharmaceutical Business Overview
11.17.3 Chuankang Pharmaceutical MedroxyProgesterone Introduction
11.17.4 Chuankang Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.17.5 Chuankang Pharmaceutical Recent Development
11.18 GMP
11.18.1 GMP Company Details
11.18.2 GMP Business Overview
11.18.3 GMP MedroxyProgesterone Introduction
11.18.4 GMP Revenue in MedroxyProgesterone Business (2016-2021)
11.18.5 GMP Recent Development
11.18 Hubei Gedian Renfu Pharmaceutical
.1 Hubei Gedian Renfu Pharmaceutical Company Details
.2 Hubei Gedian Renfu Pharmaceutical Business Overview
.3 Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Introduction
.4 Hubei Gedian Renfu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
.5 Hubei Gedian Renfu Pharmaceutical Recent Development
11.20 Shanghai Xinhualian Pharmaceutical
11.20.1 Shanghai Xinhualian Pharmaceutical Company Details
11.20.2 Shanghai Xinhualian Pharmaceutical Business Overview
11.20.3 Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Introduction
11.20.4 Shanghai Xinhualian Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.20.5 Shanghai Xinhualian Pharmaceutical Recent Development
11.21 China Resources Zizhu Pharmaceutical
11.21.1 China Resources Zizhu Pharmaceutical Company Details
11.21.2 China Resources Zizhu Pharmaceutical Business Overview
11.21.3 China Resources Zizhu Pharmaceutical MedroxyProgesterone Introduction
11.21.4 China Resources Zizhu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.21.5 China Resources Zizhu Pharmaceutical Recent Development
11.22 Guangzhou Langsheng Pharmaceutical
11.22.1 Guangzhou Langsheng Pharmaceutical Company Details
11.22.2 Guangzhou Langsheng Pharmaceutical Business Overview
11.22.3 Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Introduction
11.22.4 Guangzhou Langsheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021)
11.22.5 Guangzhou Langsheng Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global MedroxyProgesterone Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Tablets
Table 4. Key Players of Capsule
Table 5. Key Players of Long-Acting Injection (Powder)
Table 6. Key Players of Cycloprogesterone Oil Injection
Table 7. Key Players of Medroxyprogesterone Silicone Rubber Vaginal Ring
Table 8. Global MedroxyProgesterone Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global MedroxyProgesterone Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global MedroxyProgesterone Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global MedroxyProgesterone Market Share by Regions (2016-2021)
Table 12. Global MedroxyProgesterone Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global MedroxyProgesterone Market Share by Regions (2022-2027)
Table 14. MedroxyProgesterone Market Trends
Table 15. MedroxyProgesterone Market Drivers
Table 16. MedroxyProgesterone Market Challenges
Table 17. MedroxyProgesterone Market Restraints
Table 18. Global MedroxyProgesterone Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global MedroxyProgesterone Market Share by Players (2016-2021)
Table 20. Global Top MedroxyProgesterone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MedroxyProgesterone as of 2020)
Table 21. Ranking of Global Top MedroxyProgesterone Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by MedroxyProgesterone Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players MedroxyProgesterone Product Solution and Service
Table 25. Date of Enter into MedroxyProgesterone Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 28. Global MedroxyProgesterone Revenue Market Share by Type (2016-2021)
Table 29. Global MedroxyProgesterone Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global MedroxyProgesterone Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global MedroxyProgesterone Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global MedroxyProgesterone Revenue Market Share by Application (2016-2021)
Table 33. Global MedroxyProgesterone Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global MedroxyProgesterone Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 36. North America MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 38. North America MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific MedroxyProgesterone Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific MedroxyProgesterone Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa MedroxyProgesterone Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa MedroxyProgesterone Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa MedroxyProgesterone Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa MedroxyProgesterone Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa MedroxyProgesterone Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa MedroxyProgesterone Market Size by Country (2022-2027) & (US$ Million)
Table 65. Carlo Erba Company Details
Table 66. Carlo Erba Business Overview
Table 67. Carlo Erba MedroxyProgesterone Product
Table 68. Carlo Erba Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 69. Carlo Erba Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer MedroxyProgesterone Product
Table 73. Pfizer Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. Polichem Company Details
Table 76. Polichem Business Overview
Table 77. Polichem MedroxyProgesterone Product
Table 78. Polichem Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 79. Polichem Recent Development
Table 80. Nanjing Chengong Pharmaceutical Company Details
Table 81. Nanjing Chengong Pharmaceutical Business Overview
Table 82. Nanjing Chengong Pharmaceutical MedroxyProgesterone Product
Table 83. Nanjing Chengong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 84. Nanjing Chengong Pharmaceutical Recent Development
Table 85. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
Table 86. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 87. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) MedroxyProgesterone Product
Table 88. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 89. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 90. Beijing Yimin Pharmaceutical Company Details
Table 91. Beijing Yimin Pharmaceutical Business Overview
Table 92. Beijing Yimin Pharmaceutical MedroxyProgesterone Product
Table 93. Beijing Yimin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 94. Beijing Yimin Pharmaceutical Recent Development
Table 95. Guangzhou Kanghe Pharmaceutical Company Details
Table 96. Guangzhou Kanghe Pharmaceutical Business Overview
Table 97. Guangzhou Kanghe Pharmaceutical MedroxyProgesterone Product
Table 98. Guangzhou Kanghe Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 99. Guangzhou Kanghe Pharmaceutical Recent Development
Table 100. Zhejiang Xianju Pharmaceutical Company Details
Table 101. Zhejiang Xianju Pharmaceutical Business Overview
Table 102. Zhejiang Xianju Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 103. Zhejiang Xianju Pharmaceutical Recent Development
Table 104. Beijing Kangbide Pharmaceutical Company Details
Table 105. Beijing Kangbide Pharmaceutical Business Overview
Table 106. Beijing Kangbide Pharmaceutical MedroxyProgesterone Product
Table 107. Beijing Kangbide Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 108. Beijing Kangbide Pharmaceutical Recent Development
Table 109. Harbin Outi Pharmaceutical Company Details
Table 110. Harbin Outi Pharmaceutical Business Overview
Table 111. Harbin Outi Pharmaceutical MedroxyProgesterone Product
Table 112. Harbin Outi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 113. Harbin Outi Pharmaceutical Recent Development
Table 114. Hong Kong Aomei Pharmaceutical Factory Company Details
Table 115. Hong Kong Aomei Pharmaceutical Factory Business Overview
Table 116. Hong Kong Aomei Pharmaceutical Factory MedroxyProgesterone Product
Table 117. Hong Kong Aomei Pharmaceutical Factory Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 118. Hong Kong Aomei Pharmaceutical Factory Recent Development
Table 119. Jiangxi Zezhong Pharmaceutical Company Details
Table 120. Jiangxi Zezhong Pharmaceutical Business Overview
Table 121. Jiangxi Zezhong Pharmaceutical MedroxyProgesterone Product
Table 122. Jiangxi Zezhong Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 123. Jiangxi Zezhong Pharmaceutical Recent Development
Table 124. Nanjing Housheng Pharmaceutical Company Details
Table 125. Nanjing Housheng Pharmaceutical Business Overview
Table 126. Nanjing Housheng Pharmaceutical MedroxyProgesterone Product
Table 127. Nanjing Housheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 128. Nanjing Housheng Pharmaceutical Recent Development
Table 129. Yantai Luyin Pharmaceutical Company Details
Table 130. Yantai Luyin Pharmaceutical Business Overview
Table 131. Yantai Luyin Pharmaceutical MedroxyProgesterone Product
Table 132. Yantai Luyin Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 133. Yantai Luyin Pharmaceutical Recent Development
Table 134. Beijing Langyi Pharmaceutical Company Details
Table 135. Beijing Langyi Pharmaceutical Business Overview
Table 136. Beijing Langyi Pharmaceutical MedroxyProgesterone Product
Table 137. Beijing Langyi Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 138. Beijing Langyi Pharmaceutical Recent Development
Table 139. Sinopharm group Company Details
Table 140. Sinopharm group Business Overview
Table 141. Sinopharm group MedroxyProgesterone Product
Table 142. Sinopharm group Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 143. Sinopharm group Recent Development
Table 144. Chuankang Pharmaceutical Company Details
Table 145. Chuankang Pharmaceutical Business Overview
Table 146. Chuankang Pharmaceutical MedroxyProgesterone Product
Table 147. Chuankang Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 148. Chuankang Pharmaceutical Recent Development
Table 149. GMP Company Details
Table 150. GMP Business Overview
Table 151. GMP MedroxyProgesterone Product
Table 152. GMP Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 153. GMP Recent Development
Table 154. Hubei Gedian Renfu Pharmaceutical Company Details
Table 155. Hubei Gedian Renfu Pharmaceutical Business Overview
Table 156. Hubei Gedian Renfu Pharmaceutical MedroxyProgesterone Product
Table 157. Hubei Gedian Renfu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 158. Hubei Gedian Renfu Pharmaceutical Recent Development
Table 159. Shanghai Xinhualian Pharmaceutical Company Details
Table 160. Shanghai Xinhualian Pharmaceutical Business Overview
Table 161. Shanghai Xinhualian Pharmaceutical MedroxyProgesterone Product
Table 162. Shanghai Xinhualian Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 163. Shanghai Xinhualian Pharmaceutical Recent Development
Table 164. China Resources Zizhu Pharmaceutical Company Details
Table 165. China Resources Zizhu Pharmaceutical Business Overview
Table 166. China Resources Zizhu Pharmaceutical MedroxyProgesterone Product
Table 167. China Resources Zizhu Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 168. China Resources Zizhu Pharmaceutical Recent Development
Table 169. Guangzhou Langsheng Pharmaceutical Company Details
Table 170. Guangzhou Langsheng Pharmaceutical Business Overview
Table 171. Guangzhou Langsheng Pharmaceutical MedroxyProgesterone Product
Table 172. Guangzhou Langsheng Pharmaceutical Revenue in MedroxyProgesterone Business (2016-2021) & (US$ Million)
Table 173. Guangzhou Langsheng Pharmaceutical Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global MedroxyProgesterone Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Tablets Features
Figure 4. Capsule Features
Figure 5. Long-Acting Injection (Powder) Features
Figure 6. Cycloprogesterone Oil Injection Features
Figure 7. Medroxyprogesterone Silicone Rubber Vaginal Ring Features
Figure 8. Global MedroxyProgesterone Market Share by Application: 2020 VS 2027
Figure 9. Kidney Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Endometrial Cancer Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Long-Acting Contraception Case Studies
Figure 14. MedroxyProgesterone Report Years Considered
Figure 15. Global MedroxyProgesterone Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global MedroxyProgesterone Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global MedroxyProgesterone Market Share by Regions: 2020 VS 2027
Figure 18. Global MedroxyProgesterone Market Share by Regions (2022-2027)
Figure 19. Global MedroxyProgesterone Market Share by Players in 2020
Figure 20. Global Top MedroxyProgesterone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MedroxyProgesterone as of 2020
Figure 21. The Top 10 and 5 Players Market Share by MedroxyProgesterone Revenue in 2020
Figure 22. Global MedroxyProgesterone Revenue Market Share by Type (2016-2021)
Figure 23. Global MedroxyProgesterone Revenue Market Share by Type (2022-2027)
Figure 24. North America MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America MedroxyProgesterone Market Share by Type (2016-2027)
Figure 26. North America MedroxyProgesterone Market Share by Application (2016-2027)
Figure 27. North America MedroxyProgesterone Market Share by Country (2016-2027)
Figure 28. United States MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe MedroxyProgesterone Market Share by Type (2016-2027)
Figure 32. Europe MedroxyProgesterone Market Share by Application (2016-2027)
Figure 33. Europe MedroxyProgesterone Market Share by Country (2016-2027)
Figure 34. Germany MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific MedroxyProgesterone Market Share by Type (2016-2027)
Figure 42. Asia-Pacific MedroxyProgesterone Market Share by Application (2016-2027)
Figure 43. Asia-Pacific MedroxyProgesterone Market Share by Region (2016-2027)
Figure 44. China MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America MedroxyProgesterone Market Share by Type (2016-2027)
Figure 52. Latin America MedroxyProgesterone Market Share by Application (2016-2027)
Figure 53. Latin America MedroxyProgesterone Market Share by Country (2016-2027)
Figure 54. Mexico MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa MedroxyProgesterone Market Share by Type (2016-2027)
Figure 58. Middle East & Africa MedroxyProgesterone Market Share by Application (2016-2027)
Figure 59. Middle East & Africa MedroxyProgesterone Market Share by Country (2016-2027)
Figure 60. Turkey MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE MedroxyProgesterone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Carlo Erba Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 65. Polichem Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 66. Nanjing Chengong Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 67. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 68. Beijing Yimin Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 69. Guangzhou Kanghe Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 70. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 71. Beijing Kangbide Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 72. Harbin Outi Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 73. Hong Kong Aomei Pharmaceutical Factory Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 74. Jiangxi Zezhong Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 75. Nanjing Housheng Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 76. Yantai Luyin Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 77. Beijing Langyi Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 78. Sinopharm group Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 79. Chuankang Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 80. GMP Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 81. Hubei Gedian Renfu Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 82. Shanghai Xinhualian Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 83. China Resources Zizhu Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 84. Guangzhou Langsheng Pharmaceutical Revenue Growth Rate in MedroxyProgesterone Business (2016-2021)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
世界のメドロキシプロゲステロン酢酸塩市場 2021：企業別、地域別、種類・用途別 The Medroxyprogesterone Acetate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 世界の子宮内膜癌市場規模・現状・予測（2021年-2027年） Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual per…
- 世界の子宮内膜がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Endometrial Cancer Therapeutics Market The global Endometrial Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 世界の粉末射出成形市場規模・現状・予測（2021年-2027年） Injection Molding is a type of manufacturing technology that can use either metals or ceramics to produce small yet geometrically complex shapes that are widely used in end-user industries like the consumer products and medical devices. The adoption of leading-edge process control and monitoring sys…
- 世界の粉末射出成形市場規模・現状・予測（2021年-2027年） Injection Molding is a type of manufacturing technology that can use either metals or ceramics to produce small yet geometrically complex shapes that are widely used in end-user industries like the consumer products and medical devices. The adoption of leading-edge process control and monitoring sys…